(Q37781893)

23 August 2017

title

Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery (English)

1 reference

23 August 2017

Controversies in Oral Antiplatelet Therapy in Patients Undergoing Aortocoronary Bypass Surgery (English)

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

21 June 2024

4

Paul A Gurbel

1 reference

23 August 2017

Elisabeth Mahla

1

1 reference

23 August 2017

Helfried Metzler

2

1 reference

23 August 2017

Udaya S. Tantry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732553

21 June 2024

language of work or name

English

0 references

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

http://intl-ats.ctsnetjournals.org/cgi/content/abstract/90/3/1040

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732553

https://api.elsevier.com/content/article/PII:S0003497510009070?httpAccept=text/xml

21 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

https://api.elsevier.com/content/article/PII:S0003497510009070?httpAccept=text/plain

21 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

The Annals of Thoracic Surgery

21 June 2024

published in

1 reference

23 August 2017

volume

90

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

1040-1051

1 reference

Platelets in atherothrombosis

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Platelet activation in myocardial ischemic syndromes

21 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

21 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Blood coagulation at the site of microvascular injury: effects of low-dose aspirin

21 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Aspirin induces platelet receptor shedding via ADAM17 (TACE)

21 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk

21 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis

21 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".

21 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review

21 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery

21 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease

21 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients

21 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting

21 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies

21 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Aspirin and mortality from coronary bypass surgery

21 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline

21 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Guideline on antiplatelet and anticoagulation management in cardiac surgery

21 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Drug insight: Clopidogrel nonresponsiveness

21 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome

21 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting

21 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

21 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

21 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

21 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.

21 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

21 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

21 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Calcium-channel blockers reduce the antiplatelet effect of clopidogrel

21 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

21 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial

21 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Platelet function monitoring in patients with coronary artery disease

21 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events

21 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials

21 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

21 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

21 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial

21 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients

21 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

21 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

21 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial

21 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery

21 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Effect of clopidogrel on bleeding after coronary artery bypass surgery

21 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting

21 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel

21 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery

21 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting

21 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?

21 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution

21 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery.

21 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss

21 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28

21 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery

21 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery

21 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome

21 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting

21 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Clopidogrel use and bleeding after coronary artery bypass graft surgery

21 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis

21 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome.

21 June 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis

21 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease

21 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome

21 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes

21 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting

21 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG

21 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

What does it take to make the perfect clot?

21 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation

21 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats

21 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin

21 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery

21 June 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.ATHORACSUR.2010.04.041

21 June 2024

Identifiers

1 reference

23 August 2017

1 reference